CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
0.8223
-0.0277 (-3.26%)
At close: Jan 2, 2026, 4:00 PM EST
0.8240
+0.0017 (0.21%)
After-hours: Jan 2, 2026, 4:10 PM EST
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $16.9 million as of January 2, 2026. Its market cap has decreased by -64.35% in one year.
Market Cap
16.90M
Enterprise Value
31.10M
1-Year Change
-64.35%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $16.90M, a decrease of -83.40%. That is a compound annual growth rate of -5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 16.93M | -3.06% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |